The role of low density lipoprotein apheresis in the treatment of familial hypercholesterolemia

Therapeutic Apheresis

Volumn 1, Issue 1, 1997, Pages 13-16

  Thompson, Gilbert R ^a,c   Kitano, Yuri ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b SUDA Clinic   (Japan)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

3 Hydroxy 3 methylglutaryl coenzyme A reductase inhibitor; Apheresis; Atherosclerosis; Cholesterol; Lipoprotein(a)

Indexed keywords

CELLULOSE; DEXTRAN SULFATE; HEPARIN; LOW DENSITY LIPOPROTEIN;

APHERESIS; BLOOD; CLINICAL TRIAL; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; ISOLATION AND PURIFICATION; METHODOLOGY;

BLOOD COMPONENT REMOVAL; CELLULOSE; CLINICAL TRIALS; DEXTRAN SULFATE; HEPARIN; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; IMMUNOSORBENT TECHNIQUES; LIPOPROTEINS, LDL;

EID: 0031061194     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1997.tb00006.x     Document Type: Article

References (18)

1. de Gennes JL, Touraine R, Maunand B, Truffert J, Laudat P. Formes homozygotes cutaneo-tendineuses de xanthomatose hypercholestérolémique dans une observation famiale exemplaire. Essai de plasmaphérèse à titre de traitment héroïque. Bull Med Soc Hop Paris 1967;118:1377-1402.
2. Thompson GR, Lowenthal R, Myant NB. Plasma exchange in the management of homozygous familial hypercholesterolaemia. Lancet 1975;1:1208-11.
3. Stoffel W, Borberg H, Greve V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia. Lancet 1981;2:1005-7.
4. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985;5:613-22.
5. Kitano Y, Thompson GR. Role of LDL apheresis in the management of hypercholesterolaemia. Transfus Sci 1993;14: 269-80.
6. Gordon BR, Kelsey SF, Bilheimer DW, Brown DC, Dau PC, Gotto AM Jr, Illingworth DR, Jones PH, Leitman SF, Prihoda JS, Stein EA, Stern TN, Zavoral JH, Zwiener RJ, for the Liposorber Study Group. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Am J Cardiol 1992;70:1010-6.
7. Maher VMG, Kitano Y, Neuwirth C, Gallagher JJ, Thompson GR, Myant NB. Effective reduction of plasma LDL levels by LDL apheresis in familial defective apolipoprotein B-100. Atherosclerosis 1992;95:231-4.
8. Thiery J, Seidel D. LDL-apheresis: Clinical experience and indications in the treatment of severe hypercholesterolemia. Transfus Sci 1993;14:249-59.
9. Thompson GR, Barbir M, Okabayashi K, Trayner I, Larkin S. Plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1989;9(Suppl I):I152-7.
10. Thompson GR, Miller JP, Breslow JL. Improved survival of patients with homozygous familial hypercholesterolaemia treated by plasma exchange. Br Med J 1985;291:1671-3.
11. Webb JC, Sun X-M, McCarthy SN, Neuwirth C, Thompson GR, Knight BL, Soutar AK. Characterization of mutations in the low density lipoprotein (LDL)-receptor gene in patients with homozygous familial hypercholesterolemia, and frequency of these mutations in FH patients in the United Kingdom. J Lipid Res 1996;37:368-81.
12. Rallidis L, Nihoyannopoulos P, Thompson GR. Aortic stenosis in homozygous familial hypercholesterolaemia. Heart 1966;76:84-5.
13. Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y, Nishide T, Okamura K, Saito Y, Teramoto T. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia. Atherosclerosis 1992;95:1-13.
14. Kitabatake A, Sato H, Hori M, Kamada T, Kubori S, Hoki N, Minamino T, Yamada M, Kato T. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis. Clin Ther 1994;16:416-28.
15. Waidner T, Franzen D, Voelker W, Ritter M, Borberg H, Hombach V, Hopp HW. The effect of LDL apheresis on progression of coronary artery disease in patients with familial hypercholesterolemia. Clin Invest. 1994;72:858-63.
16. Thompson GR, Maher VMG, Matthews S, Kitano Y, Neuwirth C, Shortt MB, Davies G, Rees A, Mir A, Prescott RJ, de Feyter P, Henderson A. Familial hypercholesterolaemia regression study: A randomised trial of low-density-lipoprotein apheresis. Lancet 1995;345:811-6.
17. Gordon BR, Stein E, Jones P, Illingworth DR. Indications for low-density lipoprotein apheresis. Am J Cardiol 1994;74: 1109-12.
18. Nawrocki JW, Weiss SR, Davidson MH, Sprecher DL, Schwartz SL, Lupien PJ, Jones PH, Haber HE, Black DM. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol 1995; 15:678-82.